Outcomes of robotic surgery for inflammatory bowel disease using the Medtronic Hugo™ Robotic-Assisted Surgical platform: a single center experience

• Published in: International journal of colorectal disease 2024-10, Vol.39 (1), p.158, Article 158
• Main Authors: Rottoli, Matteo, Cardelli, Stefano, Calini, Giacomo, Alexa, Ioana Diana, Violante, Tommaso, Poggioli, Gilberto
• Format: Article
• Language: English
• Subjects: Adult; Anastomosis; Complications; Female; Gastroenterology; Hepatology; Humans; Inflammatory bowel disease; Inflammatory bowel diseases; Inflammatory Bowel Diseases - surgery; Internal Medicine; Intestine; Laparoscopy; Laparoscopy - adverse effects; Length of Stay; Male; Medicine; Medicine & Public Health; Middle Aged; Operative Time; Patient Readmission; Patients; Postoperative; Postoperative Complications - etiology; Proctology; Retrospective Studies; Robotic surgery; Robotic Surgical Procedures - adverse effects; Robotic Surgical Procedures - methods; Surgery; Treatment Outcome
• ISSN: 1432-1262; 0179-1958; 1432-1262
• DOI: 10.1007/s00384-024-04736-2

Purpose The aim of the study was to compare the perioperative outcomes of patients affected by inflammatory bowel disease (IBD) who underwent surgery performed through laparoscopy or using the Medtronic Hugo™ RAS. Methods This is a retrospective study from a prospectively maintained database comparing laparoscopic vs. robotic-assisted surgery for IBD from 01/11/2017 to 15/04/2024. All procedures were performed by a single surgeon robotic-naïve with a large experience in laparoscopic surgery for IBD. The robotic procedures were performed using the Medtronic Hugo™ RAS platform. Outcomes were 30-day postoperative complications, operative time, conversion rate, intraoperative complications, length of hospital stay, and readmission rate. Results Among 121 consecutive patients, 80 underwent laparoscopic (LG) and 41 robotic-assisted surgery (RG). Baseline, preoperative and disease-specific characteristics were comparable except for older age (50 [38–56] vs. 38 [28–54] years; p  = 0.05) and higher albumin level (42 [40–44] vs. 40 [38–42] g/L, p  = 0.006) in the RG. The intracorporeal anastomosis was more frequent in the RG (80% vs. 6%; p   2 complications (7% vs. 6%; p  = 1). Conclusion IBD surgery performed using the Medtronic Hugo™ RAS is safe and feasible, with similar postoperative outcomes when compared to the laparoscopic approach.